EMD Serono, the Rockland, Mass.-based unit of Merck KGaA, today began disclosing grant funding and payments to physicians.
EMD Serono discloses physician payments
The quarterly disclosures are required by the biopharmaceutical company's corporate integrity agreement with HHS' inspector general's office, according to an EMD Serono news release (PDF).
The report provides data, including spending on meals, educational items, honoraria, professional fees and expenses made to physicians, from the first quarter of 2011. EMD Serono said it plans to report research-related payments to physicians in the future.
The 549-page document includes the physician's name, city, type of transaction, purpose and dollar amount. The company did not provide a total for its spending on payments to physicians and grants.
EMD Serono spent $331,300 on charitable contributions and $476,240 on continuing medical education during the first quarter of 2011.
EMD Serono and Serono Laboratories said in May that they agreed to pay $44.3 million to settle allegations that the companies illegally paid physicians kickbacks to promote or prescribe multiple sclerosis drug Rebif.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.